Enhancing dna immunization by targeting asfv antigens to sla-ii bearing cells

Vaccine

Volumn 29, Issue 33, 2011, Pages 5379-5385

  Argilaguet, J M ^a   Perez Martin E ^a   Gallardo, C ^b   Salguero, F J ^b   Borrego, B ^b   Lacasta, A ^a   Accensi, F ^a,d   Diaz I ^a   Nofrarias M ^a   Pujols, J ^a,e   Blanco, E ^b   Perez Filgueira M ^c   Escribano, J M ^c   Rodriguez F ^a  

^a CENTRE DE RECERCA EN SANITAT ANIMAL CRESA   (Spain)

^b Instituto Nacional de Investigación y Tecnología Agraria y Alimentaria   (Spain)

^c INIA   (Spain)

^d UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^e IRTA   (Spain)

Author keywords

ASFV; DNA vaccine; ScFv

Indexed keywords

AFRICAN SWINE FEVER VIRUS VACCINE; DNA VACCINE; GREEN FLUORESCENT PROTEIN; HLA DR2 ANTIGEN; LEUKOCYTE ANTIGEN; PLASMID DNA; PROTEIN P30; PROTEIN P54; SINGLE CHAIN FRAGMENT VARIABLE ANTIBODY; UNCLASSIFIED DRUG; VIRUS VACCINE;

AFRICAN SWINE FEVER; ANIMAL EXPERIMENT; ANTIBODY RESPONSE; ANTIBODY TITER; ANTIGEN EXPRESSION; ANTIGEN PRESENTING CELL; ARTICLE; CELLULAR IMMUNITY; GENE SEQUENCE; HUMORAL IMMUNITY; IMMUNE RESPONSE; MOUSE; NONHUMAN; OPEN READING FRAME; PRIORITY JOURNAL; SWINE; VIREMIA; VIRUS GENE;

EID: 79960341940     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2011.05.084     Document Type: Article

References (51)

1. Braun S. Muscular gene transfer using nonviral vectors. Curr Gene Ther 2008, 8(5 (October)):391-405.
2. Jiao S., Williams P., Berg R.K., Hodgeman B.A., Liu L., Repetto G., et al. Direct gene transfer into nonhuman primate myofibers in vivo. Hum Gene Ther 1992, 3(1 (February)):21-33.
3. Liu M.A. Immunologic basis of vaccine vectors. Immunity 2010, 33(4 (October)):504-515.
4. Babiuk L.A., Pontarollo R., Babiuk S., Loehr B., van Drunen Littel-van den Hurk S. Induction of immune responses by DNA vaccines in large animals. Vaccine 2003, 21(7-8 (January)):649-658.
5. Kutzler M.A., Weiner D.B. DNA vaccines: ready for prime time?. Nat Rev Genet 2008, 9(10 (October)):776-788.
6. Dhama K., Mahendran M., Gupta P.K., Rai A. DNA vaccines and their applications in veterinary practice: current perspectives. Vet Res Commun 2008, 32(5 (June)):341-356.
7. Bodles-Brakhop A.M., Draghia-Akli R. DNA vaccination and gene therapy: optimization and delivery for cancer therapy. Expert Rev Vaccines 2008, 7(7 (September)):1085-1101.
8. Rajcani J., Mosko T., Rezuchova I. Current developments in viral DNA vaccines: shall they solve the unsolved?. Rev Med Virol 2005, 15(5 (September-October)):303-325.
9. Liu M.A., Wahren B., Karlsson Hedestam G.B. DNA vaccines: recent developments and future possibilities. Hum Gene Ther 2006, 17(11 (November)):1051-1061.
10. van Drunen Littel-van den Hurk S., Babiuk S.L., Babiuk L.A. Strategies for improved formulation and delivery of DNA vaccines to veterinary target species. Immunol Rev 2004, 199 (June):113-125.
11. Leifert J.A., Rodriguez-Carreno M.P., Rodriguez F., Whitton J.L. Targeting plasmid-encoded proteins to the antigen presentation pathways. Immunol Rev 2004, 199(June):40-53.
12. Ruffini P.A., Grodeland G., Fredriksen A.B., Bogen B. Human chemokine MIP1alpha increases efficiency of targeted DNA fusion vaccines. Vaccine 2010, 29(2 (December)):191-199.
13. Nchinda G., Kuroiwa J., Oks M., Trumpfheller C., Park C.G., Huang Y., et al. The efficacy of DNA vaccination is enhanced in mice by targeting the encoded protein to dendritic cells. J Clin Invest 2008, 118(4 (April)):1427-1436.
14. Boyle J.S., Brady J.L., Lew A.M. Enhanced responses to a DNA vaccine encoding a fusion antigen that is directed to sites of immune induction. Nature 1998, 392(6674 (March)):408-411.
15. Holliger P., Hudson P.J. Engineered antibody fragments and the rise of single domains. Nat Biotechnol 2005, 23(9 (September)):1126-1136.
16. Demangel C., Zhou J., Choo A.B., Shoebridge G., Halliday G.M., Britton W.J. Single chain antibody fragments for the selective targeting of antigens to dendritic cells. Mol Immunol 2005, 42(8 (May)):979-985.
17. Grossmann C., Tenbusch M., Nchinda G., Temchura V., Nabi G., Stone G.W., et al. Enhancement of the priming efficacy of DNA vaccines encoding dendritic cell-targeted antigens by synergistic toll-like receptor ligands. BMC Immunol 2009, 10:43.
18. Ivanovska N., Tchorbanov A., Prechl J., Maximova V., Voynova E., Vassilev T.L. Immunization with a DNA chimeric molecule encoding a hemagglutinin peptide and a scFv CD21-specific antibody fragment induces long-lasting IgM and CTL responses to influenza virus. Vaccine 2006, 24(11 (March)):1830-1837.
19. Prechl J., Tchorbanov A., Horvath A., Baiu D.C., Hazenbos W., Rajnavolgyi E., et al. Targeting of influenza epitopes to murine CR1/CR2 using single-chain antibodies. Immunopharmacology 1999, 42(1-3 (May)):159-165.
20. Pereboev A.V., Asiedu C.K., Kawakami Y., Dong S.S., Blackwell J.L., Kashentseva E.A., et al. Coxsackievirus-adenovirus receptor genetically fused to anti-human CD40 scFv enhances adenoviral transduction of dendritic cells. Gene Ther 2002, 9(17 (Septmeber)):1189-1193.
21. Gil F., Perez-Filgueira M., Barderas M.G., Pastor-Vargas C., Alonso C., Vivanco F., et al. Targeting antigens to an invariant epitope of the MHC Class II DR molecule potentiates the immune response to subunit vaccines. Virus Res 2010, (September).
22. Barderas M.G., Rodriguez F., Gomez-Puertas P., Aviles M., Beitia F., Alonso C., et al. Antigenic and immunogenic properties of a chimera of two immunodominant African swine fever virus proteins. Arch Virol 2001, 146(9):1681-1691.
23. Gomez-Puertas P., Rodriguez F., Oviedo J.M., Brun A., Alonso C., Escribano J.M. The African swine fever virus proteins p54 and p30 are involved in two distinct steps of virus attachment and both contribute to the antibody-mediated protective immune response. Virology 1998, 243(2 (April)):461-471.
24. Bullido R., Domenech N., Alvarez B., Alonso F., Babin M., Ezquerra A., et al. Characterization of five monoclonal antibodies specific for swine class II major histocompatibility antigens and crossreactivity studies with leukocytes of domestic animals. Dev Comp Immunol 1997, 21(3 (May-June)):311-322.
25. Ramiro-Ibanez F., Escribano J.M., Alonso C. Application of a monoclonal antibody recognizing protein p30 to detect African swine fever virus-infected cells in peripheral blood. J Virol Methods 1995, 55(3 (November)):339-345.
26. Alonso C., Miskin J., Hernaez B., Fernandez-Zapatero P., Soto L., Canto C., et al. African swine fever virus protein p54 interacts with the microtubular motor complex through direct binding to light-chain dynein. J Virol 2001, 75(20 (October)):9819-9827.
27. Alcaraz C., De Diego M., Pastor M.J., Escribano J.M. Comparison of a radioimmunoprecipitation assay to immunoblotting and ELISA for detection of antibody to African swine fever virus. J Vet Diagn Invest 1990, 2(3 (July)):191-196.
28. Perez-Filgueira D.M., Gonzalez-Camacho F., Gallardo C., Resino-Talavan P., Blanco E., Gomez-Casado E., et al. Optimization and validation of recombinant serological tests for African Swine Fever diagnosis based on detection of the p30 protein produced in Trichoplusia ni larvae. J Clin Microbiol 2006, 44(9 (September)):3114-3121.
29. Ruiz Gonzalvo F., Caballero C., Martinez J., Carnero M.E. Neutralization of African swine fever virus by sera from African swine fever-resistant pigs. Am J Vet Res 1986, 47(August (8)):1858-1862.
30. Diaz I., Mateu E. Use of ELISPOT and ELISA to evaluate IFN-gamma, IL-10 and IL-4 responses in conventional pigs. Vet Immunol Immunopathol 2005, 106(June (1-2)):107-112.
31. Perez-Martin E., Grau-Roma L., Argilaguet J.M., Nofrarias M., Escribano J.M., Gomez-Sebastian S., et al. Development of two Trichoplusia ni larvae-derived ELISAs for the detection of antibodies against replicase and capsid proteins of porcine circovirus type 2 in domestic pigs. J Virol Methods 2008, 154(December (1-2)):167-174.
32. Bullido R., Alonso F., Gomez del Moral M., Ezquerra A., Alvarez B., Ortuno, et al. Monoclonal antibody 2F4/11 recognizes the alpha chain of a porcine beta 2 integrin involved in adhesion and complement mediated phagocytosis. J Immunol Methods 1996, 195(September (1-2)):125-134.
33. Reed L.J., Muench H. A simple method of estimating fifty per cent endpoint. Am J Hyg 1938, 27:493-497.
34. Alcaraz C., Brun A., Ruiz-Gonzalvo F., Escribano J.M. Cell culture propagation modifies the African swine fever virus replication phenotype in macrophages and generates viral subpopulations differing in protein p54. Virus Res 1992, 23(April (1-2)):173-182.
35. Rodriguez F., Alcaraz C., Eiras A., Yanez R.J., Rodriguez J.M., Alonso C., et al. Characterization and molecular basis of heterogeneity of the African swine fever virus envelope protein p54. J Virol 1994, 68(November (11)):7244-7252.
36. Onisk D.V., Borca M.V., Kutish G., Kramer E., Irusta P., Rock D.L. Passively transferred African swine fever virus antibodies protect swine against lethal infection. Virology 1994, 198(January (1)):350-354.
37. Ruiz Gonzalvo F., Carnero M.E., Caballero C., Martinez J. Inhibition of African swine fever infection in the presence of immune sera in vivo and in vitro. Am J Vet Res 1986, 47(June (6)):1249-1252.
38. Martins C.L., Leitao A.C. Porcine immune responses to African swine fever virus (ASFV) infection. Vet Immunol Immunopathol 1994, 43(October (1-3)):99-106.
39. Wardley R.C., Norley S.G., Wilkinson P.J., Williams S. The role of antibody in protection against African swine fever virus. Vet Immunol Immunopathol 1985, 9(July (3)):201-212.
40. Stone S.S., Hess W.R. Antibody response to inactivated preparations of African swine fever virus in pigs. Am J Vet Res 1967, 28(March (123)):475-481.
41. Forman A.J., Wardley R.C., Wilkinson P.J. The immunological response of pigs and guinea pigs to antigens of African swine fever virus. Arch Virol 1982, 74(2-3):91-100.
42. Gomez-Puertas P., Rodriguez F., Oviedo J.M., Ramiro-Ibanez F., Ruiz-Gonzalvo F., Alonso C., et al. Neutralizing antibodies to different proteins of African swine fever virus inhibit both virus attachment and internalization. J Virol 1996, 70(August (8)):5689-5694.
43. Neilan J.G., Zsak L., Lu Z., Burrage T.G., Kutish G.F., Rock D.L. Neutralizing antibodies to African swine fever virus proteins p30, p54, and p72 are not sufficient for antibody-mediated protection. Virology 2004, 319(February (2)):337-342.
44. Oura C.A., Denyer M.S., Takamatsu H., Parkhouse R.M. In vivo depletion of CD8+ T lymphocytes abrogates protective immunity to African swine fever virus. J Gen Virol 2005, 86(February (Pt 9)):2445-2450.
45. Radosevic K., Rodriguez A., Lemckert A., Goudsmit J. Heterologous prime-boost vaccinations for poverty-related diseases: advantages and future prospects. Expert Rev Vaccines 2009, 8(May (5)):577-592.
46. Ubol S., Halstead S.B. How innate immune mechanisms contribute to antibody-enhanced viral infections. Clin Vaccine Immunol 2010, 17(December (12)):1829-1835.
47. Vennema H., de Groot R.J., Harbour D.A., Dalderup M., Gruffydd-Jones T., Horzinek M.C., et al. Early death after feline infectious peritonitis virus challenge due to recombinant vaccinia virus immunization. J Virol 1990, 64(March (3)):1407-1409.
48. Gollins S.W., Porterfield J.S. Flavivirus infection enhancement in macrophages: radioactive and biological studies on the effect of antibody on viral fate. J Gen Virol 1984, 65(August (Pt 8)):1261-1272.
49. Delgado M.F., Coviello S., Monsalvo A.C., Melendi G.A., Hernandez J.Z., Batalle J.P., et al. Lack of antibody affinity maturation due to poor Toll-like receptor stimulation leads to enhanced respiratory syncytial virus disease. Nat Med 2009, 15(January (1)):34-41.
50. Takada A., Kawaoka Y. Antibody-dependent enhancement of viral infection: molecular mechanisms and in vivo implications. Rev Med Virol 2003, 13(November-December (6)):387-398.
51. Revilla Y., Pena L., Vinuela E. Interferon-gamma production by African swine fever virus-specific lymphocytes. Scand J Immunol 1992, 35(February (2)):225-230.